Rigel Pharmaceuticals Inc (RIGL)
0.9504
-0.03
(-3.27%)
USD |
NASDAQ |
May 17, 16:00
1.02
+0.07
(+7.32%)
After-Hours: 20:00
Rigel Pharmaceuticals Accounts Receivable (Quarterly): 27.51M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 27.51M |
December 31, 2023 | 30.55M |
September 30, 2023 | 23.55M |
June 30, 2023 | 20.82M |
March 31, 2023 | 29.37M |
December 31, 2022 | 40.32M |
September 30, 2022 | 15.52M |
June 30, 2022 | 17.20M |
March 31, 2022 | 15.24M |
December 31, 2021 | 15.47M |
September 30, 2021 | 14.99M |
June 30, 2021 | 17.37M |
March 31, 2021 | 142.20M |
December 31, 2020 | 15.97M |
September 30, 2020 | 14.63M |
June 30, 2020 | 11.73M |
March 31, 2020 | 9.66M |
December 31, 2019 | 10.11M |
September 30, 2019 | 11.55M |
June 30, 2019 | 6.933M |
March 31, 2019 | 5.614M |
December 31, 2018 | 4.077M |
September 30, 2018 | 3.273M |
June 30, 2018 | 1.62M |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.095M |
March 31, 2016 | 0.195M |
December 31, 2015 | 0.203M |
September 30, 2015 | 0.163M |
June 30, 2015 | 0.35M |
March 31, 2015 | 0.106M |
December 31, 2014 | 5.75M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 5.75M |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | 0.00 |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
6.933M
Minimum
Jun 2019
142.20M
Maximum
Mar 2021
24.53M
Average
15.75M
Median
Accounts Receivable (Quarterly) Benchmarks
Nektar Therapeutics | 3.617M |
Avid Bioservices Inc | 18.54M |
Stereotaxis Inc | 3.953M |
Cara Therapeutics Inc | 1.718M |
Ardelyx Inc | 28.16M |